Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/28/2012US8252302 Methods and compositions to treat hemorrhagic conditions of the brain
08/28/2012US8252276 Cyclodextrin-based polymers for therapeutics delivery
08/28/2012US8252275 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
08/28/2012US8252274 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
08/28/2012US8252270 Composition for making-up the skin comprising at least one resin, at least one block copolymer and at least one solid fatty substance, free from volatile oil
08/28/2012US8252268 Formoterol and mometasone aerosol formulations
08/28/2012US8252046 Drug-delivery endovascular stent and method for treating restenosis
08/28/2012US8252045 Drug delivery from electroactive molecularly imprinted polymer
08/28/2012CA2825216A1 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents
08/28/2012CA2720631C 3-indazolyl-4-pyridylisothiazoles
08/28/2012CA2711101C Fused heterocyclic derivatives and methods of use as c-met inhibitors
08/28/2012CA2703125C Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer
08/28/2012CA2692013C Modulators of ccr9 receptor and methods of use thereof
08/28/2012CA2656910C Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent
08/28/2012CA2656079C Cyclic amine compound
08/28/2012CA2645724C Use of polyols to obtain stable polymorphous forms of rifaximin
08/28/2012CA2639700C New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them
08/28/2012CA2606185C Mono-lysine salts of azole compounds
08/28/2012CA2598224C Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
08/28/2012CA2589744C Pyrrolinidium derivatives as m3 muscarinic receptors
08/28/2012CA2581666C Process for producing concentrate of unsaturated fatty acid
08/28/2012CA2570559C Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
08/28/2012CA2566970C Use of furan alkyl for preparing an antidiabetic drug
08/28/2012CA2566846C Pdk-1/akt signaling inhibitors
08/28/2012CA2563302C Combinations of glycopyrrolate and beta2 adrenoceptor agonists
08/28/2012CA2561509C Anti-itching agent
08/28/2012CA2553715C Anthranilamide compounds, process for their production and pesticides containing them
08/28/2012CA2551060C Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
08/28/2012CA2550441C Benzimidazole derivatives and medical uses thereof
08/28/2012CA2549053C Tricyclic steroid hormone nuclear receptor modulators
08/28/2012CA2540500C Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
08/28/2012CA2539384C Mechanism-based targeted pancreatic beta cell imaging and therapy
08/28/2012CA2534493C Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
08/28/2012CA2533846C Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer
08/28/2012CA2522579C Topical formulation of ivermectin for the treatment of dermatological conditions
08/28/2012CA2519679C Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
08/28/2012CA2513746C Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
08/28/2012CA2508171C Nicotinamide-based kinase inhibitors
08/28/2012CA2507217C Compositions and methods for treating neuropathic sensory loss
08/28/2012CA2506523C Novel biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
08/28/2012CA2506319C Stents comprising biodegradable polymers associated with therapeutic agents
08/28/2012CA2497353C Method for preventing or reducing secondary fractures after hip fracture
08/28/2012CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels
08/28/2012CA2476939C Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2012CA2455776C Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
08/28/2012CA2455710C Calcium salts with cytotoxic activity
08/28/2012CA2454073C Mutations in ion channels
08/28/2012CA2453337C Methods and materials for the treatment of testosterone deficiency in men
08/28/2012CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa
08/28/2012CA2437812C Compositions and methods for modulation of vascular structure and/or function
08/28/2012CA2432978C Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/28/2012CA2415718C 7-substituted tetracycline compounds
08/28/2012CA2409930C Use of zoledronate for the manufacture of a medicament for the treatment of bone metabolism diseases
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/28/2012CA2284110C An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
08/25/2012CA2733732A1 Formulations of canfosfamide and their preparation
08/25/2012CA2733021A1 Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus
08/25/2012CA2731871A1 Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders
08/23/2012WO2012112982A2 Hydrogel encapsulated cells and anti-inflammatory drugs
08/23/2012WO2012112969A1 Aminoindane compounds and use thereof in treating pain
08/23/2012WO2012112966A1 Compounds and methods for treatment of hypertension
08/23/2012WO2012112965A1 Compounds and methods of treating diabetes
08/23/2012WO2012112964A2 PYRIDO[4,3-b]INDOLE AND PYRIDO[3,4-b]INDOLE DERIVATIVES AND METHODS OF USE
08/23/2012WO2012112963A1 Compounds and methods for treatment of hypertension
08/23/2012WO2012112962A1 Compounds and methods of treating diabetes
08/23/2012WO2012112961A1 Compounds and methods of treating hypertension
08/23/2012WO2012112956A2 Compounds and methods for targeting leukemic stem cells
08/23/2012WO2012112951A1 COMPOSITIONS COMPRISING PEROXY α-KETOCARBOXYLIC ACID AND METHODS FOR PRODUCING AND USING THE SAME
08/23/2012WO2012112946A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012WO2012112945A1 Use of matrix metalloproteinase inhibitors to treat tuberculosis
08/23/2012WO2012112940A1 Treatment of submental fat
08/23/2012WO2012112922A1 Methods for synthesizing molybdopterin precursor z derivatives
08/23/2012WO2012112919A1 Stromal derived factor inhibition and cxcr4 blockade
08/23/2012WO2012112918A1 Methods for treating diseases of the retina
08/23/2012WO2012112902A1 Methods of preparing free polyunsaturated fatty acids
08/23/2012WO2012112847A1 mTOR/JAK INHIBITOR COMBINATION THERAPY
08/23/2012WO2012112841A2 [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation
08/23/2012WO2012112796A2 Perfluoro(n-butylcyclohexane) compositions and uses thereof
08/23/2012WO2012112791A1 Radiation countermeasure agents
08/23/2012WO2012112743A1 Chroman - spirocyclic piperidine amides as modulators of ion channels
08/23/2012WO2012112742A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/23/2012WO2012112733A1 Cathepsin c inhibitors
08/23/2012WO2012112699A2 Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to corneal tissue
08/23/2012WO2012112670A1 Novel lipogenic inhibitors and uses thereof
08/23/2012WO2012112638A1 Cross reference to related applications
08/23/2012WO2012112636A1 Cylindrical ocular inserts
08/23/2012WO2012112623A2 Rxrg modulators for the treatment of cancer
08/23/2012WO2012112570A1 SORAFENIB DERIVATIVES AS sEH INHIBITORS
08/23/2012WO2012112568A1 Small molecule inhibitors for treating parasitic infections
08/23/2012WO2012112567A1 Small molecule inhibitors of agbl2
08/23/2012WO2012112566A1 Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea
08/23/2012WO2012112543A2 Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to scleral tissue
08/23/2012WO2012112531A1 Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
08/23/2012WO2012112527A1 Omega 3 formulations comprising epa, dha and dpa for treatment of risk factors for cardiovascular disease
08/23/2012WO2012112525A1 PERIPHERIALLY ACTING μ OPIOID ANTAGONISTS
08/23/2012WO2012112520A1 A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
08/23/2012WO2012112517A1 Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd)
08/23/2012WO2012112511A1 Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
08/23/2012WO2012112492A1 4-hydroxybutyric acid deuterated analogs
08/23/2012WO2012112462A1 Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
1 ... 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 ... 7860